TFP
AGIO icon

Tilia Fiduciary Partners’s Agios Pharmaceuticals AGIO Stock Holding History

Tilia Fiduciary Partners’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-38
Closed -$1.08K – 104
2023
Q2 		$1.08K Hold
38
– – ﹤0.01% 498
2023
Q1 		$873 Hold
38
– – ﹤0.01% 486
2022
Q4 		$1.07K Hold
38
– – ﹤0.01% 474
2022
Q3 		$1K Hold
38
– – ﹤0.01% 488
2022
Q2 		$1K Hold
38
– – ﹤0.01% 501
2022
Q1 		$1K Hold
38
– – ﹤0.01% 511
2021
Q4 		$1K Buy
+38
New +$1.53K ﹤0.01% 534

Other funds holding AGIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tilia Fiduciary Partners's AGIO Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of Agios Pharmaceuticals (AGIO) in Q3 2023, closing a stake of 38 shares — an estimated $1.08K sold.

Tilia Fiduciary Partners first reported a position in AGIO in Q4 2021 and held it in 7 quarters. The position peaked at $1.08K in Q2 2023. 145 funds tracked by Wall St. Rank hold AGIO as of Q3 2023.

  • Tilia Fiduciary Partners reported no remaining Agios Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 38 Agios Pharmaceuticals shares in Q3 2023, an estimated $1.08K.
  • Tilia Fiduciary Partners first reported a position in Agios Pharmaceuticals in Q4 2021 and held it in 7 quarters.
  • Tilia Fiduciary Partners's Agios Pharmaceuticals position peaked at $1.08K in Q2 2023.
  • 145 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.